nodes	percent_of_prediction	percent_of_DWPC	metapath
Azelaic Acid—Iridocyclitis—Prednisolone—multiple sclerosis	0.0536	0.071	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism of steroid hormones and vitamin D—CYP27B1—multiple sclerosis	0.0476	0.22	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism of steroid hormones and vitamin D—CYP24A1—multiple sclerosis	0.0476	0.22	CbGpPWpGaD
Azelaic Acid—Localized exfoliation—Triamcinolone—multiple sclerosis	0.03	0.0398	CcSEcCtD
Azelaic Acid—Aminolevulinic acid—SLC15A2—multiple sclerosis	0.0286	1	CrCbGaD
Azelaic Acid—SRD5A2—Androgen biosynthesis—POMC—multiple sclerosis	0.0258	0.119	CbGpPWpGaD
Azelaic Acid—Redness—Cladribine—multiple sclerosis	0.0242	0.032	CcSEcCtD
Azelaic Acid—Hypertrichosis—Triamcinolone—multiple sclerosis	0.0213	0.0282	CcSEcCtD
Azelaic Acid—Hypertrichosis—Methylprednisolone—multiple sclerosis	0.0212	0.0281	CcSEcCtD
Azelaic Acid—Leukoderma—Prednisolone—multiple sclerosis	0.0207	0.0274	CcSEcCtD
Azelaic Acid—Hypertrichosis—Dexamethasone—multiple sclerosis	0.0193	0.0256	CcSEcCtD
Azelaic Acid—Hypertrichosis—Betamethasone—multiple sclerosis	0.0193	0.0256	CcSEcCtD
Azelaic Acid—Leukoderma—Triamcinolone—multiple sclerosis	0.019	0.0252	CcSEcCtD
Azelaic Acid—Leukoderma—Methylprednisolone—multiple sclerosis	0.019	0.0251	CcSEcCtD
Azelaic Acid—Leukoderma—Betamethasone—multiple sclerosis	0.0173	0.0229	CcSEcCtD
Azelaic Acid—Leukoderma—Dexamethasone—multiple sclerosis	0.0173	0.0229	CcSEcCtD
Azelaic Acid—Application site reaction—Triamcinolone—multiple sclerosis	0.0172	0.0228	CcSEcCtD
Azelaic Acid—Hypertrichosis—Prednisone—multiple sclerosis	0.0168	0.0223	CcSEcCtD
Azelaic Acid—Leukoderma—Prednisone—multiple sclerosis	0.015	0.0199	CcSEcCtD
Azelaic Acid—Leukoderma—Methotrexate—multiple sclerosis	0.0126	0.0166	CcSEcCtD
Azelaic Acid—AKR1D1—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.0112	0.0516	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.0112	0.0516	CbGpPWpGaD
Azelaic Acid—Stinging—Prednisolone—multiple sclerosis	0.0109	0.0144	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism of steroid hormones and vitamin D—POMC—multiple sclerosis	0.0107	0.0494	CbGpPWpGaD
Azelaic Acid—Acne—Prednisolone—multiple sclerosis	0.0104	0.0138	CcSEcCtD
Azelaic Acid—Tingling sensation—Methylprednisolone—multiple sclerosis	0.01	0.0133	CcSEcCtD
Azelaic Acid—Stinging—Triamcinolone—multiple sclerosis	0.00998	0.0132	CcSEcCtD
Azelaic Acid—Acne—Triamcinolone—multiple sclerosis	0.00961	0.0127	CcSEcCtD
Azelaic Acid—Acne—Methylprednisolone—multiple sclerosis	0.00959	0.0127	CcSEcCtD
Azelaic Acid—Paraesthesia—Fingolimod—multiple sclerosis	0.00921	0.0122	CcSEcCtD
Azelaic Acid—Tingling sensation—Dexamethasone—multiple sclerosis	0.00913	0.0121	CcSEcCtD
Azelaic Acid—Tingling sensation—Betamethasone—multiple sclerosis	0.00913	0.0121	CcSEcCtD
Azelaic Acid—Stinging—Dexamethasone—multiple sclerosis	0.00906	0.012	CcSEcCtD
Azelaic Acid—Stinging—Betamethasone—multiple sclerosis	0.00906	0.012	CcSEcCtD
Azelaic Acid—Acne—Betamethasone—multiple sclerosis	0.00872	0.0116	CcSEcCtD
Azelaic Acid—Acne—Dexamethasone—multiple sclerosis	0.00872	0.0116	CcSEcCtD
Azelaic Acid—AKR1D1—Bile acid and bile salt metabolism—ALB—multiple sclerosis	0.00812	0.0375	CbGpPWpGaD
Azelaic Acid—Dermatitis contact—Triamcinolone—multiple sclerosis	0.00799	0.0106	CcSEcCtD
Azelaic Acid—Skin exfoliation—Triamcinolone—multiple sclerosis	0.00772	0.0102	CcSEcCtD
Azelaic Acid—Skin exfoliation—Methylprednisolone—multiple sclerosis	0.0077	0.0102	CcSEcCtD
Azelaic Acid—Acne—Prednisone—multiple sclerosis	0.00759	0.0101	CcSEcCtD
Azelaic Acid—Pruritus—Fingolimod—multiple sclerosis	0.00726	0.00962	CcSEcCtD
Azelaic Acid—Dermatitis contact—Betamethasone—multiple sclerosis	0.00725	0.0096	CcSEcCtD
Azelaic Acid—Dermatitis contact—Dexamethasone—multiple sclerosis	0.00725	0.0096	CcSEcCtD
Azelaic Acid—Erythema—Cladribine—multiple sclerosis	0.00713	0.00944	CcSEcCtD
Azelaic Acid—Skin exfoliation—Betamethasone—multiple sclerosis	0.007	0.00928	CcSEcCtD
Azelaic Acid—Skin exfoliation—Dexamethasone—multiple sclerosis	0.007	0.00928	CcSEcCtD
Azelaic Acid—Skin exfoliation—Prednisone—multiple sclerosis	0.0061	0.00808	CcSEcCtD
Azelaic Acid—Dry skin—Prednisolone—multiple sclerosis	0.00585	0.00775	CcSEcCtD
Azelaic Acid—Oedema—Cladribine—multiple sclerosis	0.00582	0.00771	CcSEcCtD
Azelaic Acid—Paraesthesia—Cladribine—multiple sclerosis	0.00522	0.00692	CcSEcCtD
Azelaic Acid—Skin exfoliation—Methotrexate—multiple sclerosis	0.0051	0.00675	CcSEcCtD
Azelaic Acid—Asthma—Triamcinolone—multiple sclerosis	0.00507	0.00672	CcSEcCtD
Azelaic Acid—Pain—Cladribine—multiple sclerosis	0.00497	0.00659	CcSEcCtD
Azelaic Acid—Dry skin—Betamethasone—multiple sclerosis	0.00488	0.00647	CcSEcCtD
Azelaic Acid—Dry skin—Dexamethasone—multiple sclerosis	0.00488	0.00647	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.00488	0.0225	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.00488	0.0225	CbGpPWpGaD
Azelaic Acid—Erythema—Mitoxantrone—multiple sclerosis	0.00468	0.00621	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.00435	0.0201	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.00435	0.0201	CbGpPWpGaD
Azelaic Acid—Hypersensitivity—Cladribine—multiple sclerosis	0.00429	0.00568	CcSEcCtD
Azelaic Acid—Dry skin—Prednisone—multiple sclerosis	0.00425	0.00563	CcSEcCtD
Azelaic Acid—Pruritus—Cladribine—multiple sclerosis	0.00412	0.00545	CcSEcCtD
Azelaic Acid—Erythema—Prednisolone—multiple sclerosis	0.00384	0.00509	CcSEcCtD
Azelaic Acid—Oedema—Mitoxantrone—multiple sclerosis	0.00382	0.00507	CcSEcCtD
Azelaic Acid—Rash—Cladribine—multiple sclerosis	0.00367	0.00486	CcSEcCtD
Azelaic Acid—Dermatitis—Cladribine—multiple sclerosis	0.00366	0.00485	CcSEcCtD
Azelaic Acid—Erythema—Triamcinolone—multiple sclerosis	0.00353	0.00468	CcSEcCtD
Azelaic Acid—Erythema—Methylprednisolone—multiple sclerosis	0.00353	0.00467	CcSEcCtD
Azelaic Acid—Hypersensitivity—Azathioprine—multiple sclerosis	0.00348	0.00462	CcSEcCtD
Azelaic Acid—Paraesthesia—Mitoxantrone—multiple sclerosis	0.00343	0.00455	CcSEcCtD
Azelaic Acid—Asthma—Methotrexate—multiple sclerosis	0.00335	0.00444	CcSEcCtD
Azelaic Acid—Pain—Mitoxantrone—multiple sclerosis	0.00327	0.00433	CcSEcCtD
Azelaic Acid—Erythema—Dexamethasone—multiple sclerosis	0.00321	0.00425	CcSEcCtD
Azelaic Acid—Erythema—Betamethasone—multiple sclerosis	0.00321	0.00425	CcSEcCtD
Azelaic Acid—Oedema—Prednisolone—multiple sclerosis	0.00314	0.00416	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism—SRM—multiple sclerosis	0.00308	0.0142	CbGpPWpGaD
Azelaic Acid—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.00306	0.00405	CcSEcCtD
Azelaic Acid—Rash—Azathioprine—multiple sclerosis	0.00298	0.00395	CcSEcCtD
Azelaic Acid—Dermatitis—Azathioprine—multiple sclerosis	0.00298	0.00395	CcSEcCtD
Azelaic Acid—Oedema—Triamcinolone—multiple sclerosis	0.00288	0.00382	CcSEcCtD
Azelaic Acid—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00282	0.00373	CcSEcCtD
Azelaic Acid—Paraesthesia—Prednisolone—multiple sclerosis	0.00282	0.00373	CcSEcCtD
Azelaic Acid—Erythema—Prednisone—multiple sclerosis	0.00279	0.0037	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism—SRM—multiple sclerosis	0.00275	0.0127	CbGpPWpGaD
Azelaic Acid—Pain—Prednisolone—multiple sclerosis	0.00268	0.00355	CcSEcCtD
Azelaic Acid—Oedema—Betamethasone—multiple sclerosis	0.00262	0.00347	CcSEcCtD
Azelaic Acid—Oedema—Dexamethasone—multiple sclerosis	0.00262	0.00347	CcSEcCtD
Azelaic Acid—Paraesthesia—Triamcinolone—multiple sclerosis	0.00259	0.00343	CcSEcCtD
Azelaic Acid—Paraesthesia—Methylprednisolone—multiple sclerosis	0.00258	0.00342	CcSEcCtD
Azelaic Acid—Pain—Triamcinolone—multiple sclerosis	0.00247	0.00327	CcSEcCtD
Azelaic Acid—Rash—Mitoxantrone—multiple sclerosis	0.00241	0.00319	CcSEcCtD
Azelaic Acid—Dermatitis—Mitoxantrone—multiple sclerosis	0.00241	0.00319	CcSEcCtD
Azelaic Acid—Paraesthesia—Betamethasone—multiple sclerosis	0.00235	0.00311	CcSEcCtD
Azelaic Acid—Paraesthesia—Dexamethasone—multiple sclerosis	0.00235	0.00311	CcSEcCtD
Azelaic Acid—Erythema—Methotrexate—multiple sclerosis	0.00233	0.00309	CcSEcCtD
Azelaic Acid—Hypersensitivity—Prednisolone—multiple sclerosis	0.00231	0.00306	CcSEcCtD
Azelaic Acid—Oedema—Prednisone—multiple sclerosis	0.00228	0.00302	CcSEcCtD
Azelaic Acid—Pain—Betamethasone—multiple sclerosis	0.00224	0.00297	CcSEcCtD
Azelaic Acid—Pain—Dexamethasone—multiple sclerosis	0.00224	0.00297	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism—CYP27B1—multiple sclerosis	0.00217	0.01	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—CYP24A1—multiple sclerosis	0.00217	0.01	CbGpPWpGaD
Azelaic Acid—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00213	0.00282	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.00212	0.00981	CbGpPWpGaD
Azelaic Acid—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.00212	0.00281	CcSEcCtD
Azelaic Acid—Paraesthesia—Prednisone—multiple sclerosis	0.00205	0.00271	CcSEcCtD
Azelaic Acid—Pruritus—Triamcinolone—multiple sclerosis	0.00204	0.0027	CcSEcCtD
Azelaic Acid—Pruritus—Methylprednisolone—multiple sclerosis	0.00204	0.0027	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism—GPC5—multiple sclerosis	0.00199	0.00918	CbGpPWpGaD
Azelaic Acid—Rash—Prednisolone—multiple sclerosis	0.00198	0.00262	CcSEcCtD
Azelaic Acid—Dermatitis—Prednisolone—multiple sclerosis	0.00198	0.00262	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism—CYP24A1—multiple sclerosis	0.00194	0.00894	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—CYP27B1—multiple sclerosis	0.00194	0.00894	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.00189	0.00874	CbGpPWpGaD
Azelaic Acid—Pruritus—Dexamethasone—multiple sclerosis	0.00185	0.00245	CcSEcCtD
Azelaic Acid—Pruritus—Betamethasone—multiple sclerosis	0.00185	0.00245	CcSEcCtD
Azelaic Acid—Rash—Triamcinolone—multiple sclerosis	0.00182	0.00241	CcSEcCtD
Azelaic Acid—Dermatitis—Triamcinolone—multiple sclerosis	0.00182	0.00241	CcSEcCtD
Azelaic Acid—Rash—Methylprednisolone—multiple sclerosis	0.00181	0.0024	CcSEcCtD
Azelaic Acid—Dermatitis—Methylprednisolone—multiple sclerosis	0.00181	0.0024	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism—GPC5—multiple sclerosis	0.00177	0.00818	CbGpPWpGaD
Azelaic Acid—Paraesthesia—Methotrexate—multiple sclerosis	0.00171	0.00227	CcSEcCtD
Azelaic Acid—Hypersensitivity—Prednisone—multiple sclerosis	0.00168	0.00222	CcSEcCtD
Azelaic Acid—Rash—Dexamethasone—multiple sclerosis	0.00165	0.00219	CcSEcCtD
Azelaic Acid—Rash—Betamethasone—multiple sclerosis	0.00165	0.00219	CcSEcCtD
Azelaic Acid—Dermatitis—Betamethasone—multiple sclerosis	0.00165	0.00218	CcSEcCtD
Azelaic Acid—Dermatitis—Dexamethasone—multiple sclerosis	0.00165	0.00218	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism—RRM1—multiple sclerosis	0.00165	0.0076	CbGpPWpGaD
Azelaic Acid—Pain—Methotrexate—multiple sclerosis	0.00163	0.00216	CcSEcCtD
Azelaic Acid—Pruritus—Prednisone—multiple sclerosis	0.00161	0.00214	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism—RRM1—multiple sclerosis	0.00147	0.00678	CbGpPWpGaD
Azelaic Acid—Rash—Prednisone—multiple sclerosis	0.00144	0.0019	CcSEcCtD
Azelaic Acid—Dermatitis—Prednisone—multiple sclerosis	0.00144	0.0019	CcSEcCtD
Azelaic Acid—Hypersensitivity—Methotrexate—multiple sclerosis	0.0014	0.00186	CcSEcCtD
Azelaic Acid—Pruritus—Methotrexate—multiple sclerosis	0.00135	0.00179	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.00128	0.0059	CbGpPWpGaD
Azelaic Acid—Rash—Methotrexate—multiple sclerosis	0.0012	0.00159	CcSEcCtD
Azelaic Acid—Dermatitis—Methotrexate—multiple sclerosis	0.0012	0.00159	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.00114	0.00526	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.0011	0.00507	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.001	0.00462	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.000978	0.00452	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—BCHE—multiple sclerosis	0.000946	0.00437	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000892	0.00412	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—BCHE—multiple sclerosis	0.000843	0.00389	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—APOE—multiple sclerosis	0.000569	0.00263	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—APOE—multiple sclerosis	0.000507	0.00234	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—POMC—multiple sclerosis	0.000489	0.00226	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—ALB—multiple sclerosis	0.000446	0.00206	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—POMC—multiple sclerosis	0.000436	0.00201	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—ALB—multiple sclerosis	0.000397	0.00183	CbGpPWpGaD
